Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Clinical trial NCT02565615 · COMPLETED

Trial details

NCT number: NCT02565615
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Coronary Artery Disease, Hypercholesterolemia, Hypertension

Start date: 2016-06-22
Primary completion: 2018-08-31
Enrollment: 5115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.